Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix

Hirohiko Okamura, Kaya Yoshida, Kazuhiko Ochiai, Tatsuji Haneji

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The serine/threonine protein phosphatase 2A (PP2A) participates in regulating many important physiological processes such as control of cell cycle, growth, and division. On the other hand, Osterix is a zinc-finger-containing transcription factor that is essential for the differentiation of osteoblasts and regulation of many bone-related genes. Here we examined the effect of okadaic acid (OA), a specific inhibitor of PP2A, on bone formation in vivo and the molecular mechanism regulated by PP2A Cα in osteoblast differentiation. Administration of 1. nM OA to the calvarial region in mice increased bone mineral density, as shown by μ CT, while histomorphological analysis showed an increase in mineral apposition and bone thickness in the same region. In addition, treatment with 1. nM OA stimulated osteoblast differentiation and the expression of Osterix, bone sialoprotein (Bsp), and osteocalcin (OCN) in mouse osteoblastic MC3T3-E1 cells. Moreover, the expression and phosphatase activity of PP2A Cα was decreased in the initial step of osteoblast differentiation, which was in parallel with an increase in Osterix expression. To further clarify the role of PP2A Cα in osteoblast differentiation, we constructed PP2A knock-down cells by infecting MC3T3-E1 cells with a lentivirus expressing shRNA specific for the PP2A Cα Accordingly, the silencing of PP2A Cα in MC3T3-E1 cells dramatically increased osteoblast differentiation and mineralization, which were accompanied with expressions of Osterix, Bsp, and OCN. Our data indicate that PP2A Cα plays an important role in the regulation of bone formation and osteoblast differentiation through the bone-related genes.

Original languageEnglish
Pages (from-to)368-375
Number of pages8
JournalBone
Volume49
Issue number3
DOIs
Publication statusPublished - Sep 2011
Externally publishedYes

Fingerprint

Protein Phosphatase 2
Phosphoprotein Phosphatases
Osteoblasts
Osteogenesis
Transcription Factors
Bone and Bones
Okadaic Acid
Integrin-Binding Sialoprotein
Osteocalcin
Physiological Phenomena
Lentivirus
Zinc Fingers
Threonine
Phosphoric Monoester Hydrolases
Bone Density
Serine
Small Interfering RNA
Genes
Minerals
Cell Cycle

Keywords

  • Bone formation
  • Differentiation
  • Osteoblasts
  • Osterix
  • Protein phosphatase 2A

ASJC Scopus subject areas

  • Physiology
  • Endocrinology, Diabetes and Metabolism
  • Histology

Cite this

Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix. / Okamura, Hirohiko; Yoshida, Kaya; Ochiai, Kazuhiko; Haneji, Tatsuji.

In: Bone, Vol. 49, No. 3, 09.2011, p. 368-375.

Research output: Contribution to journalArticle

@article{8a977ecda9f74ab6a9021c61db80e8d8,
title = "Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix",
abstract = "The serine/threonine protein phosphatase 2A (PP2A) participates in regulating many important physiological processes such as control of cell cycle, growth, and division. On the other hand, Osterix is a zinc-finger-containing transcription factor that is essential for the differentiation of osteoblasts and regulation of many bone-related genes. Here we examined the effect of okadaic acid (OA), a specific inhibitor of PP2A, on bone formation in vivo and the molecular mechanism regulated by PP2A Cα in osteoblast differentiation. Administration of 1. nM OA to the calvarial region in mice increased bone mineral density, as shown by μ CT, while histomorphological analysis showed an increase in mineral apposition and bone thickness in the same region. In addition, treatment with 1. nM OA stimulated osteoblast differentiation and the expression of Osterix, bone sialoprotein (Bsp), and osteocalcin (OCN) in mouse osteoblastic MC3T3-E1 cells. Moreover, the expression and phosphatase activity of PP2A Cα was decreased in the initial step of osteoblast differentiation, which was in parallel with an increase in Osterix expression. To further clarify the role of PP2A Cα in osteoblast differentiation, we constructed PP2A knock-down cells by infecting MC3T3-E1 cells with a lentivirus expressing shRNA specific for the PP2A Cα Accordingly, the silencing of PP2A Cα in MC3T3-E1 cells dramatically increased osteoblast differentiation and mineralization, which were accompanied with expressions of Osterix, Bsp, and OCN. Our data indicate that PP2A Cα plays an important role in the regulation of bone formation and osteoblast differentiation through the bone-related genes.",
keywords = "Bone formation, Differentiation, Osteoblasts, Osterix, Protein phosphatase 2A",
author = "Hirohiko Okamura and Kaya Yoshida and Kazuhiko Ochiai and Tatsuji Haneji",
year = "2011",
month = "9",
doi = "10.1016/j.bone.2011.06.004",
language = "English",
volume = "49",
pages = "368--375",
journal = "Bone",
issn = "8756-3282",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix

AU - Okamura, Hirohiko

AU - Yoshida, Kaya

AU - Ochiai, Kazuhiko

AU - Haneji, Tatsuji

PY - 2011/9

Y1 - 2011/9

N2 - The serine/threonine protein phosphatase 2A (PP2A) participates in regulating many important physiological processes such as control of cell cycle, growth, and division. On the other hand, Osterix is a zinc-finger-containing transcription factor that is essential for the differentiation of osteoblasts and regulation of many bone-related genes. Here we examined the effect of okadaic acid (OA), a specific inhibitor of PP2A, on bone formation in vivo and the molecular mechanism regulated by PP2A Cα in osteoblast differentiation. Administration of 1. nM OA to the calvarial region in mice increased bone mineral density, as shown by μ CT, while histomorphological analysis showed an increase in mineral apposition and bone thickness in the same region. In addition, treatment with 1. nM OA stimulated osteoblast differentiation and the expression of Osterix, bone sialoprotein (Bsp), and osteocalcin (OCN) in mouse osteoblastic MC3T3-E1 cells. Moreover, the expression and phosphatase activity of PP2A Cα was decreased in the initial step of osteoblast differentiation, which was in parallel with an increase in Osterix expression. To further clarify the role of PP2A Cα in osteoblast differentiation, we constructed PP2A knock-down cells by infecting MC3T3-E1 cells with a lentivirus expressing shRNA specific for the PP2A Cα Accordingly, the silencing of PP2A Cα in MC3T3-E1 cells dramatically increased osteoblast differentiation and mineralization, which were accompanied with expressions of Osterix, Bsp, and OCN. Our data indicate that PP2A Cα plays an important role in the regulation of bone formation and osteoblast differentiation through the bone-related genes.

AB - The serine/threonine protein phosphatase 2A (PP2A) participates in regulating many important physiological processes such as control of cell cycle, growth, and division. On the other hand, Osterix is a zinc-finger-containing transcription factor that is essential for the differentiation of osteoblasts and regulation of many bone-related genes. Here we examined the effect of okadaic acid (OA), a specific inhibitor of PP2A, on bone formation in vivo and the molecular mechanism regulated by PP2A Cα in osteoblast differentiation. Administration of 1. nM OA to the calvarial region in mice increased bone mineral density, as shown by μ CT, while histomorphological analysis showed an increase in mineral apposition and bone thickness in the same region. In addition, treatment with 1. nM OA stimulated osteoblast differentiation and the expression of Osterix, bone sialoprotein (Bsp), and osteocalcin (OCN) in mouse osteoblastic MC3T3-E1 cells. Moreover, the expression and phosphatase activity of PP2A Cα was decreased in the initial step of osteoblast differentiation, which was in parallel with an increase in Osterix expression. To further clarify the role of PP2A Cα in osteoblast differentiation, we constructed PP2A knock-down cells by infecting MC3T3-E1 cells with a lentivirus expressing shRNA specific for the PP2A Cα Accordingly, the silencing of PP2A Cα in MC3T3-E1 cells dramatically increased osteoblast differentiation and mineralization, which were accompanied with expressions of Osterix, Bsp, and OCN. Our data indicate that PP2A Cα plays an important role in the regulation of bone formation and osteoblast differentiation through the bone-related genes.

KW - Bone formation

KW - Differentiation

KW - Osteoblasts

KW - Osterix

KW - Protein phosphatase 2A

UR - http://www.scopus.com/inward/record.url?scp=79960585241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960585241&partnerID=8YFLogxK

U2 - 10.1016/j.bone.2011.06.004

DO - 10.1016/j.bone.2011.06.004

M3 - Article

VL - 49

SP - 368

EP - 375

JO - Bone

JF - Bone

SN - 8756-3282

IS - 3

ER -